SCHEMBL6687727

SCHEMBL6687727

COc1ccc(NC(C)c2ccc(OC)cc2)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.82
GAA P10253 6/20 0.58
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
ACHE P22303 1/20 0.53
MAPT P10636 4/20 0.52
KDM4E B2RXH2 3/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
RAB9A P51151 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
MAPK1 P28482 2/20 0.52
NPC1 O15118 2/20 0.52
THRB P10828 1/20 0.52
RECQL P46063 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
HPGD P15428 2/20 0.51
KCNH3 Q9ULD8 2/20 0.50
ACACB O00763 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15003942 1.00 ALDH1A1 (0.82) ALDH1A1GAACA1CA2ACHE
SCHEMBL15326794 0.93 ALDH1A1 (0.72) ALDH1A1GAACA1CA2ACHE
SCHEMBL16574229 0.91 ALDH1A1 (0.70) ALDH1A1GAACA1CA2ACHE
SCHEMBL28440821 0.91 ALDH1A1 (0.70) ALDH1A1GAACA1CA2ACHE
SCHEMBL16574226 0.91 ALDH1A1 (0.70) ALDH1A1GAACA1CA2ACHE
SCHEMBL15004002 0.90 ALDH1A1 (1.00) ALDH1A1GAAMAPTKDM4EL3MBTL1
SCHEMBL3172125 0.90 ALDH1A1 (1.00) ALDH1A1GAAMAPTKDM4EL3MBTL1
SCHEMBL15137443 0.90 ALDH1A1 (1.00) ALDH1A1GAAMAPTKDM4EL3MBTL1
SCHEMBL11221573 0.90 ALDH1A1 (0.86) ALDH1A1GAACA1CA2ACHE
SCHEMBL16574227 0.87 ALDH1A1 (0.64) ALDH1A1GAAMAPTKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2836497-B1 CATALYST COMPOUNDS UNIV LIVERPOOL (GB) 2016-03-23 EP disclosed
WO-2013153407-A1 CATALYST COMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2013-10-17 WO disclosed
US-20040147762-A1 Asymmetric reductive amination of ketones NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-07-29 US disclosed
WO-2004058982-A2 ASYMMETRIC REDUCTIVE AMINATION OF KETONES PENN STATE RESEARCH FOUNDATION (US) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147762-A1 Asymmetric reductive amination of ketones AKR7A2, PDK2, AADAT ALDH1A1 205/4885GAA 3335/4885CA1 2786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.